MACKENZIE FINANCIAL CORP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$163,000
-47.4%
58,257
+7.3%
0.00%
Q1 2022$310,000
-37.2%
54,282
+0.3%
0.00%
-100.0%
Q4 2021$494,000
+52.9%
54,135
+79.0%
0.00%
Q3 2021$323,000
-31.7%
30,238
-0.7%
0.00%
-100.0%
Q2 2021$473,000
+19.4%
30,466
+24.7%
0.00%0.0%
Q1 2021$396,000
-26.7%
24,426
-4.2%
0.00%0.0%
Q4 2020$540,000
+155.9%
25,510
+184.7%
0.00%0.0%
Q4 2019$211,0008,9600.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders